JAKARTA – Y&R Group Indonesia has won two significant accounts, pan-regional creative and strategic consultancy, for multinational pharmaceutical giant Merck.
Y&R has just been awarded the regional creative duties for Merck’s neurotropic vitamin Neurobion. This concluded a four-agency pitch, followed by strategy and testing across key target markets Indonesia, India and the Philippines.
Prior to that, Y&R was appointed to handle strategy consultancy for Merck’s iron supplement Sangobion.
“I am very pleased with our co-operation with Y&R Indonesia. Not only has the team managed to come up with a strong creative idea that works across our regional markets in Asia, but the strategic thinking behind the brands are also strong. I am also thankful that I get a highly dedicated professional team. The energy and commitment we receive from the team is marvellous. This is a very important new campaign for us, not only for Indonesia, but also for the region, as we are transforming Neurobion from a fully prescription driven product to an over the counter product. I do wish this new regional campaign will translate into flying sales performance. The same high expectation goes for the Sangobion strategy consultancy as the output will be used for creating a strong foundation for the upcoming new product under our core brand – Sangobion,” said Feni Herawati, Head of Marketing, Consumer Health – Pharmaceuticals Division.
Commenting on the win, Y&R Group Indonesia CEO John Domas said, “Two more great wins for Y&R Indonesia as momentum continues in 2014. Being recognised for both our creative and strategic strength by a major multinational like Merck is testament to our agency capabilities across Y&R Advertising, The Campaign Palace and VML Qais Indonesia.”
